ÂÜÀòÂÒÂ×

Joshua Brostoff has extensive work experience in the medical field. Joshua started their career as a Physician in general medicine and infectious disease at NHS in 2003 and continued in this role until 2013. Following this, they worked as a Medical Affairs Manager at Sanofi Pasteur MSD, where they were involved in adult vaccine programs. Joshua then joined Sanofi and held various roles including Medical Advisor for the Cardiovascular division, Senior Medical Advisor for North Sea Cluster studies, and Clinical Study Director in the Immunology, Inflammation, and Infectious Disease therapy areas. Joshua also worked as a Visiting Lecturer in Medical Ethics at King's College London and currently serves as a Medical Director at Aimmune Therapeutics since 2019.

Joshua Brostoff's education history is as follows:

Joshua Brostoff attended the University of Birmingham from 1996 to 2003, where they obtained a degree in Medicine (MBChB). Joshua then studied at UCL, although the specific dates of their enrollment are not provided. During their time at UCL, they pursued a Bachelor of Science (BSc) in Population health.

In 2016, Joshua Brostoff enrolled at King's College London and completed a Master of Arts (M.A.) degree in Medical Ethics and Law in 2018.

In addition to their formal education, Joshua Brostoff has obtained several certifications. In 2006, they received the MRCP certification from the Royal College of Physicians. Joshua further enhanced their medical expertise with a Diploma in Tropical Medicine and Hygiene (DTM&H) from the University of Liverpool in 2007. Joshua also obtained the MRCEM certification from The Royal College of Emergency Medicine and the Diploma of the Royal College of Obstetricians and Gynaecologists (DRCOG) from the Royal College of Obstetricians and Gynaecologists in 2008. Joshua completed a Diploma in Medical Education from The University of Dundee in 2009.

Continuing their professional development, Joshua obtained the Specialty Certificate Exam in Acute Medicine from the Royal College of Physicians in 2011. Joshua further pursued certifications in pharmaceutical medicine, including the Diploma in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine (year not specified) and the Membership of the Faculty of Pharmaceutical Medicine (MFPM) in 2015. In 2016, they obtained a Certificate in Good Clinical Practice from the Royal College of Physicians. Finally, in 2017, Joshua received a Diploma in Legal Medicine (DLM) from the Faculty of Forensic and Legal Medicine.

These certifications highlight Joshua Brostoff's commitment to expanding their knowledge and expertise in various medical fields beyond their formal education.